Condition: Knee Osteoarthritis · Sponsor: Shanghai IxCell Biotechnology Co., LTD
To evaluate the efficacy of IxCell hUC-MSC-O in the treatment of patients with knee osteoarthritis. To evaluate the safety of IxCell hUC-MSC-O in the treatment of patients with knee osteoarthritis.
This description comes directly from the study's public registry record.
Jie Zhao · 86-21-23271699 · 13301815365@189.cn
Always discuss trial participation with your own doctor first.
| The Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06716281